$6.48
0.000.00%
At close: -
$6.34
-0.14-2.16%
After Hours: Jan 27, 8:15 AM EDT
Kezar Life Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kezar Life Sciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-2.78 | $-3.10 | 10.3 % |
Q2 | 2024-08-13 | $-2.80 | $-3.20 | 12.5 % |
Q1 | 2024-05-09 | $-3.00 | $-3.30 | 9.09 % |
Q4 | 2024-03-14 | $-4.40 | $-3.80 | -15.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $0 | $800.00K | -100.0 % |
Q2 | 2024-08-13 | $0 | $750.00K | -100.0 % |
Q1 | 2024-05-09 | $0 | $400.00K | -100.0 % |
Kezar Life Sciences (KZR) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-2.78, which beat the estimate of $-3.10.
The Actual Revenue was $0K, which missed the estimate of $800K.
Browse earnings estimates, EPS, and revenue on all stocks.